0001209191-18-005638.txt : 20180126 0001209191-18-005638.hdr.sgml : 20180126 20180126164600 ACCESSION NUMBER: 0001209191-18-005638 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180124 FILED AS OF DATE: 20180126 DATE AS OF CHANGE: 20180126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arbuckle Stuart A CENTRAL INDEX KEY: 0001557290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 18552513 MAIL ADDRESS: STREET 1: VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-24 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001557290 Arbuckle Stuart A C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP\Chief Commercial Officer Common Stock 2018-01-24 4 M 0 4310 91.05 A 46262 D Common Stock 2018-01-24 4 M 0 4659 86.52 A 50921 D Common Stock 2018-01-24 4 S 0 8969 169.00 D 41952 D Common Stock 140 I 401(k) Stock Option (Right to Buy) 91.05 2018-01-24 4 M 0 4310 0.00 D 2026-02-01 Common Stock 4310 19397 D Stock Option (Right to Buy) 86.52 2018-01-24 4 M 0 4659 0.00 D 2027-02-02 Common Stock 4659 20193 D Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 2/2/2016. The option vests in 16 quarterly installments from 2/3/2017. /s/ Omar White, Attorney-in-Fact 2018-01-26